How Vascular Risk Factors Worsen Brain Health in NMOSD

How Vascular Risk Factors Worsen Brain Health in NMOSD
Credibility
Interest
Share:2 min read
Key Takeaway

In people with NMOSD, common vascular risk factors like smoking or high blood pressure make brain and spinal cord damage worse and are linked to more disability.

What They Found

Researchers compared 28 people with NMOSD to 56 healthy people using brain and neck MRIs and checked for vascular risks like smoking, high blood pressure, and diabetes. People with NMOSD had more white matter lesions in the brain and more spinal cord damage than healthy people, and their overall brain size and certain deep brain areas were smaller. A special MRI measure of fluid movement in the brain (DTI-ALPS) was lower in NMOSD when vascular risks were present; this measure is like checking how well the brain’s plumbing moves fluid. Higher disability scores were linked to worse spinal cord damage and poorer brain fluid movement, meaning these imaging signs relate to how people feel and function. Having vascular risk factors made the link between poor brain fluid flow and disability stronger, suggesting blood vessel problems add to the injury caused by NMOSD.

Who Should Care and Why

People with NMOSD and their caregivers should care because common, changeable risks — like smoking or uncontrolled blood pressure — can make neurological damage and symptoms worse, much like adding extra weight to an already cracked bridge. Neurologists and primary care doctors should pay attention to vascular health in NMOSD patients, since treating these risks could slow extra damage. Care teams can use this information to prioritize simple steps (quit smoking, control blood pressure, manage diabetes) that may help protect the brain and spinal cord over time. Family members who help with health visits or medications can encourage and support lifestyle changes that reduce these risks, such as scheduling appointments or helping with medication reminders. This means everyday actions, like quitting smoking or taking blood pressure medicine, might directly affect disease outcomes and daily abilities.

Important Considerations

This study had a small number of NMOSD patients, so findings need confirmation in larger groups before we can be certain. The MRI measures and links to disability show associations (they go together) but do not prove that vascular risks cause the damage. Also, not all vascular risks showed the same effect, and some results need more research to know which specific changes in care will help most.

AI-generated summary — for informational purposes only, not medical advice

Article Topics:
Brain atrophyCerebrovascular risk factorsDTI-ALPSMRINeuromyelitis optica spectrum disorder

You May Also Like

Gut Bacteria and MS: What You Need to Know
Gut Bacteria and MS: What You Need to Know

12/31/2026

Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li

Read More
Exercise changes brain networks tied to MS fatigue
Exercise changes brain networks tied to MS fatigue

7/1/2026

Study shows aerobic exercise alters brain circuits linked to automatic body control and fatigue in M

Read More
Eye Scan + Blood Test Help Spot MS Who May Worsen
Eye Scan + Blood Test Help Spot MS Who May Worsen

7/1/2026

A simple eye scan and a blood test for sGFAP together help identify people with MS at higher risk of

Read More
New MS Treatments: Slowing Progression and Repairing Nerves
New MS Treatments: Slowing Progression and Repairing Nerves

6/1/2026

Emerging MS therapies aim to slow long-term worsening, target a possible viral trigger, and repair n

Read More
MS starting after 50 linked to steady relapse-free disability
MS starting after 50 linked to steady relapse-free disability

5/22/2026

Study finds MS beginning at age 50+ more often causes steady disability without relapses, suggesting

Read More
New CD8 Immune Cells Found to Drive Brain Inflammation
New CD8 Immune Cells Found to Drive Brain Inflammation

5/22/2026

Mouse study shows a CD8 immune cell type drives brain inflammation in MS-like disease; blocking IFN-

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.